Imax may not have returned to pre-pandemic levels, but the cinema company got a lift during its most recent quarterly earnings from the renewed interest in moviegoing, as well as the arrival of a few well-timed blockbusters.
For the three-month period ending in June, revenues at the company climbed to $51 million, a 475.4 percent jump from the $8.9 million that Imax reported in the year-ago quarter. Of course, there’s a good reason those comparisons are so dramatic. Last summer was a period when much of Imax’s network of theaters were shuttered due to the spread of COVID-19 or only operating at limited capacity. Imax also reported a net loss attributable to common shareholders of $9.2 million, or 16 cents per diluted share. That was a significant improvement on the $26 million the company lost in the year-ago period.
Analysts projected that Imax would post a loss of 25 cents per share on sales of $43.8 million. Wall Street seemed to like what it saw. Shares of Imax climbed nearly 4 percent in after-hours trading.
The box office, at least in countries with lower rates of COVID, has showed signs of life in recent months. It’s been buoyed by several high profile releases such as “Fast 9,” “A Quiet Place Part II” and “Godzilla vs. Kong,” all of which were among Imax’s highest-grossing films last quarter. If the Delta variant doesn’t scramble plans, the rest of 2021 should field many tentpole films, including a sequel to James Bond, “Dune,” and Marvel’s “Shang-Chi” and “The Eternals.”
Imax reported cash-on-hand of $214.1 million and $241 million in debt.
More to come…